BioSpace News Archive

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the Indigo® Aspiration System.

Project funded through CQDM Quantum Leap program with support from Merck will explore potential of Fusion’s ONETest to improve diagnosis of respiratory tract infections

Emergex Vaccines Holding Limited, a biotechnology company developing set-point vaccines to prevent serious infectious diseases, announced that it has secured over US$11 million in a Series A round.

Surgery that moves the jaws forward can result in significant improvements in long-term quality of life – including functional outcomes and sleep quality – in patients with obstructive sleep apnea, according to a new study.

Axonics Modulation Technologies, Inc. reported preliminary unaudited revenue of approximately $10 million for the fourth quarter of 2019 as compared to $0.5 million in the prior year period.

Co-Diagnostics, Inc. announced that it has been recognized as a company that represents the Nasdaq Biotech Index in leading the nation in solving America’s Healthcare challenges following a year of several Company milestones, and invited to ring the Nasdaq Stock Market opening bell on January 13 in San Francisco, California.

Galafold Revenue of $181 Million for Full-Year 2019 and $54 Million in Q4 Reflects Continued Strong Adoption & Patient Adherence in All Key Global Regions

Bio-Techne Corporation announced that management will host a conference call on Tuesday, February 4, 2020, at 8:00 a.m. CST to review second quarter 2020 financial results.

MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval for the FRED® device for the treatment of brain aneurysms.

The investment arm of Debiopharm, a private, Swiss corporate fund specialized in Smart Data and Digital Health, leads the Series A